Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03095274
Brief Title: Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin (DUNE)

First Submitted : March 23, 2017
First Submitted that Met QC Criteria : March 28, 2017
First Posted : March 29, 2017

Last Update Submitted that Met QC Criteria : November 27, 2018
Last Update Posted : November 28, 2018